The New Mexico Senate has unanimously approved a bipartisan resolution requesting that state officials research the therapeutic potential of psilocybin and explore the creation of a regulatory framework to provide access to the psychedelic.
The body voted 37-0 to pass the measure from Senate Minority Whip Craig Brandt (R) and Sen. Jeff Steinborn (D).
The action came days after the Health and Public Affairs Committee had approved the legislation, also unanimously.
As “memorial” legislation, the proposal isn’t binding. Rather, it would represent a formal request for the state Department of Health to “study the efficacy of using psilocybin mushrooms for therapeutic treatments and the establishment of a program for psilocybin mushrooms to be used for therapeutic medical treatments.”
The whereas section of the resolution cites various studies supporting the therapeutic benefits of psilocybin for conditions such as major depression and substance misuse, while pointing out that the federal Food and Drug Administration (FDA) has designated the psychedelic as a “breakthrough therapy.”
To that end, the measure states that the health department should look into “necessary statutory or regulatory framework for developing” a state-level psilocybin program.
“It turns out that medical mushrooms, psilocybin, has proven to be medically efficacious for the
Read full article on Marijuana Moment
